Lombaard J, Moolasart V, Lutaakome J, Van Solingen-Ristea R, et al. Pharmacokinetics, Safety and Antiviral Activity of Rilpivirine in Antiretroviral-naive Children With HIV >/=6 to <12 Years Old: Week 48 and Final Analysis of Cohort 2 From the Open-label, Phase 2 PAINT Study. Pediatr Infect Dis J 2025 Apr 18. doi: 10.1097/INF.0000000000004828.
PMID: 40249797